This clinical trial, sponsored by Yonsei University, aims to evaluate the efficacy of alfacalcidol in enhancing muscle function in postmenopausal women with osteoporosis and functional sarcopenia. The study will involve 340 participants over a one-year period, comparing outcomes between the alfacalcidol and placebo groups.